The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic-Reference-Cited by-同舟云学术

The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic

Published:2022-02-11 Issue:1 Volume:100 Page:7-18
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Vizel A. A.¹^ORCID,Vizel I. Yu.²^ORCID,Sagdieva M. K.³,Yarkaeva F. F.⁴

Affiliation:

1. Kazan State Medical University

2. Kazan State Medical University; Central Tuberculosis Research Institute

3. City Polyclinic no. 10

4. Ministry of Health of the Republic of Tatarstan

Abstract

The article analyzes 46 publications on the use of ICS for COVID-19. Both research results and their discussion by specialists are presented. The expediency of continuing basic therapy, including ICS, has been demonstrated in the event of COVID-19 in patients with bronchial asthma and chronic obstructive pulmonary disease. The risk of local immunosuppressive action of ICS has been compared with the ability to suppress inflammation in the initial period of COVID-19. Analysis of the publications suggests that it is safe to prescribe ICS to patients with COVID-19 as well as it is advisable to use them in the initial stages of this disease.

Publisher

LLC "Medical Knowledge and Technologies"

Subject

General Medicine

Reference48 articles.

1. Аrutyunov G.P., Tarlovskaya E.I., Аrutyunov А.G., Belenkov Yu.N., Konradi А.O., Lopatin Yu.M., Rebrov А.P. et al. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry (Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2). Kardiologia, 2021, vol. 61, no. 9, pp. 20-32. (In Russ.) doi: 10.18087/cardio.2021.9.n1680.

2. Vizel А., Vizel I., Gizatullina E. Pneumonia in COPD patients receiving inhaled glucocorticosteroids. Vrach, 2017, no. 1, pp. 17-23. (In Russ.)

3. Vizel А.А., Yaushev M.F., Khalfiev I.N. The use of the inhaled steroid of Ingacort in treatment of infiltrative pulmonary tuberculosis. Pulmonologiya, 2000, no. 1, pp. 31-34. (In Russ.)

4. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (2019-nCoV) Versiya 13.1 (09.11.2021): 209-2010. [Provisional guidelines on prevention, diagnostics and treatment of the new coronavirus infection (2019-nCoV). Version 13.1 (09.11.2021): 209-2010].

5. Gudima G.O., Khaitov R.M., Kudlay D.А., Khaitov M.R. Molecular immunological aspects of diagnosis, prevention and treatment of coronavirus infection. Immunologiya, 2021, vol. 42, no. 3, pp. 198-210. (In Russ.) doi: https://doi.org/10.33029/0206-4952-2021-42-3-198-210.